Dun & Bradstreet (DNB) Tops Q3 EPS by 17c, Reaffirms Guidance
Get Alerts DNB Hot Sheet
Price: $9.15 --0%
Financial Fact:
Equity in Net Income of Affiliates: 1.2M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Equity in Net Income of Affiliates: 1.2M
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Dun & Bradstreet (NYSE: DNB) reported Q3 EPS of $1.84, $0.17 better than the analyst estimate of $1.67. Revenue for the quarter came in at $406.2 million versus the consensus estimate of $420.05 million.
Dun & Bradstreet reaffirmed FY2015 guidance.
- As Adjusted revenue growth 6% to 9%, before the effect of foreign exchange;
- As Adjusted operating income of flat to 4%;
- As Adjusted diluted EPS of (3%) to 1%; and
- Free cash flow of $255 million to $285 million, which excludes the impact of legacy tax matters and any potential regulatory fines associated with our China operations.
For earnings history and earnings-related data on Dun & Bradstreet (DNB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share